Researchers at the University of Washington have updated a traditional Chinese medicine to create a compound that is more than 1,200 times more specific in killing certain kinds of cancer cells than currently available drugs, heralding the possibility of a more effective chemotherapy drug with minimal side effects. The compound is currently being licensed to Artemisia Biomedical Inc. for commercialization.
Related external links (will open a new window):
Related WTC links:
– end of post –